Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Apnea, Obstructive 5Lung Neoplasms 5Sleep Apnea Syndromes 3Polycystic Ovary Syndrome 3Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Thrombocythemia, Essential 1Small Cell Lung Carcinoma 1Polycythemia Vera 1Obesity 1Microcephaly, Primary Autosomal Recessive, 6 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

padeliporfin 5Nivolumab 3vedolizumab 2atezolizumab 2anlotinib 2Therapeutics 2Surveys and Questionnaires 2Riluzole 2Radiotherapy 2LDP-02 2Ipilimumab 2Infliximab 2Immunoglobulin G 2Genetic Testing 2Fecal Microbiota Transplantation 2Disulfides 2Carboplatin 2CT-P13 2tislelizumab 1relatlimab 1prednylidene 1pembrolizumab 1palladium-bacteriopheophorbide 1olaparib 1niraparib 1ixabepilone 1ferumoxtran-10 1enfortumab vedotin 1deltacortene 1darolutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urogenital Neoplasms × Continuous Positive Airway Pressure × Clear all
NCT07111039 2026-05-18

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡